Amwill Healthcare’s shares will debut on the BSE SME platform with an IPO price of Rs 111 each. The IPO saw moderate investor interest, driven by institutional support. Amwill focuses on derma-cosmetic products, outsourcing manufacturing and distribution to third parties. India’s $14 billion beauty industry is growing rapidly due to online sales and a trend toward personalised products.
A record run! NSE IPO draws Rs 90,000 crore demand, takes subscription crown among India’s 5 largest offerings
NSE IPO GMP Live Updates: The Rs 22,561.57 crore public issue, the second-largest IPO in India by issue size after Hyundai Motor India, received bids